{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:08:15Z","timestamp":1773817695378,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jval.2019.03.011","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T20:10:51Z","timestamp":1558037451000},"page":"684-692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparing the Noncomparable: The Need for Equivalence Measures That Make Sense in Health-Economic Evaluations"],"prefix":"10.1016","volume":"22","author":[{"given":"F. Reed","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank I.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelby D.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meenakshi","family":"Bewtra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jval.2019.03.011_bib1","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1287\/opre.18.6.1021","article-title":"A\u00a0health-status index and its application to health-services outcomes","volume":"18","author":"Fanshel","year":"1970","journal-title":"Operations Res"},{"issue":"2","key":"10.1016\/j.jval.2019.03.011_bib2","first-page":"118","article-title":"A\u00a0utility maximization model for evaluation of health care programs","volume":"7","author":"Torrance","year":"1972","journal-title":"Health Services Res"},{"key":"10.1016\/j.jval.2019.03.011_bib3","series-title":"Theory of Games and Economic Behavior","author":"Von Neumann","year":"1944"},{"key":"10.1016\/j.jval.2019.03.011_bib4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1287\/opre.28.1.206","article-title":"Utility functions for life years and health status","volume":"28","author":"Pliskin","year":"1980","journal-title":"Oper Res"},{"key":"10.1016\/j.jval.2019.03.011_bib5","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2002"},{"key":"10.1016\/j.jval.2019.03.011_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1007734401982","article-title":"Characterizing QALYs under a general rank dependent utility model","volume":"15","author":"Bleichrodt","year":"1997","journal-title":"J\u00a0Risk Uncertainty"},{"issue":"11","key":"10.1016\/j.jval.2019.03.011_bib7","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0895-4356(99)00074-8","article-title":"Are health states \u201ctimeless\u201d? The case of the standard gamble method","volume":"52","author":"Bala","year":"1999","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.jval.2019.03.011_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jclinepi.2004.10.005","article-title":"Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey","volume":"58","author":"Franic","year":"2005","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jval.2019.03.011_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpubeco.2016.11.012","article-title":"The insurance value of medical innovation","volume":"145","author":"Lakdawalla","year":"2017","journal-title":"J\u00a0Public Econ"},{"issue":"2","key":"10.1016\/j.jval.2019.03.011_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jval.2016.11.028","article-title":"Patient versus physician valuation of durable survival gains: implications for value framework assessments","volume":"20","author":"Shafrin","year":"2017","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.jval.2019.03.011_bib11","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1377\/hlthaff.2011.1300","article-title":"How cancer patients value hope and the implications for cost-effectiveness assessments of high-cost cancer therapies","volume":"31","author":"Lakdawalla","year":"2012","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.jval.2019.03.011_bib12","first-page":"1","article-title":"Theory and methods of economic evaluation of health care","volume":"4","author":"Johannesson","year":"1996","journal-title":"Dev Health Econ Public Policy"},{"issue":"8","key":"10.1016\/j.jval.2019.03.011_bib13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0895-4356(98)00036-5","article-title":"Valuing outcomes in health care: a comparison of willingness to pay and quality-adjusted life-years","volume":"51","author":"Bala","year":"1998","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.jval.2019.03.011_bib14","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10198-017-0943-1","article-title":"Does the approach to economic evaluation in health care depend on culture, values, and institutional context?","volume":"19","author":"Torbica","year":"2018","journal-title":"Eur J Health Econ"},{"issue":"3","key":"10.1016\/j.jval.2019.03.011_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0167-6296(01)00136-9","article-title":"A\u00a0proposal to solve the comparability problem in cost-utility analysis","volume":"21","author":"Bleichrodt","year":"2002","journal-title":"J\u00a0Health Econ"},{"issue":"3 suppl","key":"10.1016\/j.jval.2019.03.011_bib16","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1097\/00005650-198903001-00016","article-title":"Incorporating utility-based quality-of-life assessment measures in clinical trials. Two examples","volume":"27","author":"Feeny","year":"1989","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.jval.2019.03.011_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/0272989X9801800115","article-title":"The effect of search procedures on utility elicitations","volume":"18","author":"Lenert","year":"1998","journal-title":"Med Decis Making"},{"issue":"4","key":"10.1016\/j.jval.2019.03.011_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/0272989X9801800406","article-title":"Patients' utilities for cancer treatments: a study of the chained procedure for the standard gamble and time tradeoff","volume":"18","author":"Jansen","year":"1998","journal-title":"Med Decis Making"},{"issue":"3","key":"10.1016\/j.jval.2019.03.011_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0277-9536(95)00151-4","article-title":"A\u00a0note on the relationship between ex ante and expected willingness to pay for health care","volume":"42","author":"Johannesson","year":"1996","journal-title":"Soc Sci Med"},{"issue":"5","key":"10.1016\/j.jval.2019.03.011_bib20","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/1539-6924.00265","article-title":"QALYs versus WTP","volume":"22","author":"Hammitt","year":"2002","journal-title":"Risk Anal"},{"issue":"5","key":"10.1016\/j.jval.2019.03.011_bib21","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0167-6296(02)00011-5","article-title":"Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis?","volume":"21","author":"Dolan","year":"2002","journal-title":"J\u00a0Health Econ"},{"issue":"6","key":"10.1016\/j.jval.2019.03.011_bib22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0167-6296(99)00014-4","article-title":"Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost-benefit analysis?","volume":"18","author":"Bleichrodt","year":"1999","journal-title":"J\u00a0Health Econ"},{"issue":"1","key":"10.1016\/j.jval.2019.03.011_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hec.697","article-title":"A\u00a0utility-theoretic model for QALYs and willingness to pay","volume":"12","author":"Klose","year":"2003","journal-title":"Health Econ"},{"issue":"2","key":"10.1016\/j.jval.2019.03.011_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/259880","article-title":"On the concept of health capital and the demand for health","volume":"80","author":"Grossman","year":"1972","journal-title":"J\u00a0Political Economy"},{"issue":"2","key":"10.1016\/j.jval.2019.03.011_bib25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/0272989X8900900209","article-title":"Quality-adjusted life years, utility-theory, and healthy-years equivalents","volume":"9","author":"Mehrez","year":"1989","journal-title":"Med Decis Making"},{"issue":"2","key":"10.1016\/j.jval.2019.03.011_bib26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0272989X9101100212","article-title":"The healthy-years equivalents: how to measure them using the standard gamble approach","volume":"11","author":"Mehrez","year":"1991","journal-title":"Med Decis Making"},{"issue":"3","key":"10.1016\/j.jval.2019.03.011_bib27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0167-6296(93)90015-7","article-title":"Economics, health and health economics: HYEs (healthy-years equivalent) versus QALYs (quality-adjusted live-year)","volume":"12","author":"Gafni","year":"1993","journal-title":"J\u00a0Health Econ"},{"issue":"6","key":"10.1016\/j.jval.2019.03.011_bib28","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0277-9536(94)E0109-6","article-title":"Preferences for outcomes in economic evaluation: an economic approach to addressing economic problems","volume":"40","author":"Gafni","year":"1995","journal-title":"Soc Sci Med"},{"issue":"3","key":"10.1016\/j.jval.2019.03.011_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0167-6296(93)90013-5","article-title":"A\u00a0note on HYE (healthy year equivalent)","volume":"12","author":"Buckingham","year":"1993","journal-title":"J\u00a0Health Econ"},{"issue":"3","key":"10.1016\/j.jval.2019.03.011_bib30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0167-6296(93)90014-6","article-title":"QALYs vs HYEs","volume":"12","author":"Culyer","year":"1993","journal-title":"J\u00a0Health Econ"},{"issue":"4","key":"10.1016\/j.jval.2019.03.011_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0272989X9301300403","article-title":"Are healthy-years equivalents an improvement over quality-adjusted life years?","volume":"13","author":"Johannesson","year":"1993","journal-title":"Med Decis Making"},{"issue":"1","key":"10.1016\/j.jval.2019.03.011_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-6296(94)00031-X","article-title":"The myth of the HYE","volume":"14","author":"Loomes","year":"1995","journal-title":"J\u00a0Health Econ"},{"issue":"1","key":"10.1016\/j.jval.2019.03.011_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0167-6296(94)00033-Z","article-title":"QALYs and HYEs: under what conditions are they equivalent?","volume":"14","author":"Bleichrodt","year":"1995","journal-title":"J\u00a0Health Econ"},{"issue":"1","key":"10.1016\/j.jval.2019.03.011_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1017\/S0266462300010217","article-title":"Healthy years equivalents versus time trade-off. Ambiguity on certainty and uncertainty","volume":"13","author":"Rittenhouse","year":"1997","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.jval.2019.03.011_bib35","series-title":"Cost-Benefit Analysis","author":"Mishan","year":"1976"},{"key":"10.1016\/j.jval.2019.03.011_bib36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1477-7525-1-80","article-title":"Problems and solutions in calculating quality-adjusted life years (QALYs)","volume":"1","author":"Prieto","year":"2003","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"10.1016\/j.jval.2019.03.011_bib37","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/0272989X10386116","article-title":"Eliciting benefit-risk preferences and probability-weighted utility using choice-format conjoint analysis","volume":"31","author":"Van Houtven","year":"2011","journal-title":"Med Decis Making"},{"issue":"2","key":"10.1016\/j.jval.2019.03.011_bib38","first-page":"319","article-title":"Contemporary guidance for stated preference studies","volume":"4","author":"Johnston","year":"2017","journal-title":"J\u00a0Assoc Environ Resour Econ"},{"issue":"10","key":"10.1016\/j.jval.2019.03.011_bib39","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s40273-014-0181-7","article-title":"Reconceptualising the external validity of discrete choice experiments","volume":"32","author":"Lancsar","year":"2014","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2019.03.011_bib40","series-title":"Compensation Mechanisms for Job Risks: Wages, Workers' Compensation, and Product Liability","author":"Moore","year":"1990"},{"issue":"1","key":"10.1016\/j.jval.2019.03.011_bib41","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1524-4733.2008.00391.x","article-title":"Using conjoint analysis to estimate healthy-year equivalents for acute conditions: an application to vasomotor symptoms","volume":"12","author":"Johnson","year":"2009","journal-title":"Value Health"},{"issue":"45","key":"10.1016\/j.jval.2019.03.011_bib42","doi-asserted-by":"crossref","first-page":"8086","DOI":"10.1016\/j.vaccine.2011.08.041","article-title":"Healthy-days time equivalents for outcomes of acute rotavirus infections","volume":"29","author":"Hauber","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jval.2019.03.011_bib43","doi-asserted-by":"crossref","unstructured":"J.D. Lewis, M. Bewtra, F.I. Scott, et\u00a0al. Anti-TNF drugs versus long-term steroid use for patients with inflammatory bowel diseases. Patient-Centered Outcomes Research Institute (PCORI). https:\/\/doi.org\/10.25302\/11.2018.CE.12114143.","DOI":"10.25302\/11.2018.CE.12114143"},{"issue":"5","key":"10.1016\/j.jval.2019.03.011_bib44","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/ibd\/izy321","article-title":"Improved quality of life with anti-TNF therapy compared to continued corticosteroid utilization in Crohn's disease","volume":"25","author":"Scott","year":"2019","journal-title":"Inflammatory Bowel Dis"},{"issue":"4","key":"10.1016\/j.jval.2019.03.011_bib45","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","article-title":"Conjoint analysis applications in health\u2014a checklist: a report of the ISPOR good research practices for conjoint analysis task force","volume":"14","author":"Bridges","year":"2011","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.jval.2019.03.011_bib46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00054725-199712000-00004","article-title":"An evaluation of utility measurement in Crohn's disease","volume":"3","author":"Gregor","year":"1997","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jval.2019.03.011_bib47","article-title":"Structural Discrete Probability Models Derived from Theories of Choice, in Structural Analysis of Discrete Data and Econometric Applications","author":"McFadden","year":"1981"},{"key":"10.1016\/j.jval.2019.03.011_bib48","unstructured":"Patient Preference Information \u2013 Voluntary Submission, Review in Premarket Approval Applications, Humanitarian Device Exemption Applications, and De Novo Requests, and Inclusion in Decision Summaries and Device Labeling. U.S. Department of Health and Human Services, Food and Drug Administration. https:\/\/www.fda.gov\/downloads\/MedicalDevices\/DeviceRegulationandGuidance\/GuidanceDocuments\/UCM517504.pdf."},{"issue":"2","key":"10.1016\/j.jval.2019.03.011_bib49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40273-018-0734-2","article-title":"Discrete choice experiments in health economics: past, present and future","volume":"37","author":"Soekhai","year":"2019","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"10.1016\/j.jval.2019.03.011_bib50","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jval.2014.04.002","article-title":"A\u00a0program of methodological research to arrive at the New International EQ-5D-5L valuation protocol","volume":"17","author":"Oppe","year":"2014","journal-title":"Value Health"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301519301858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301519301858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:15:42Z","timestamp":1761095742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301519301858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1098301519301858"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2019.03.011","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the Noncomparable: The Need for Equivalence Measures That Make Sense in Health-Economic Evaluations","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2019.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}